INSIGHTS ON SOLID DOSE MANUFACTURING
-
![GettyImages-1465073079-pills-coated]( "Modified Release Formulations: Extending Drug Commercial Lifecycle")
Modified Release Formulations: Extending Drug Commercial LifecycleA CDMO with expertise in modified-release dosage forms can provide valuable assistance in formulation development, processing considerations, analytical challenges, and regulatory requirements.
-
![GettyImages-1087219020 Scientists wearing protective coveralls working in manufacturing laboratory]( "Solid-State Characterization Of A Small Molecule API")
Solid-State Characterization Of A Small Molecule APIEnsuring the consistency and purity of the API is paramount when developing a new drug. Learn about the importance of CRO partnerships when facing tight deadlines and complex scientific hurdles.
-
![GettyImages-648684280-Pharmaceutical_Equipment_Lab_Manufacturing_Sterile]( "A Micronization Method Enabling The Formulation Of Biopharmaceuticals")
A Micronization Method Enabling The Formulation Of BiopharmaceuticalsMicronization is key for increasing the loading efficiency and lowering the burst of microspheres. Applying lyophilization-based micronization methodology at a small scale helps to support challenging formulation development projects.
-
![Pharm Manufacturing Facility GettyImages-1087218874]( "Tips To Maintain Your Pharmaceutical Tablet Presses And Tooling")
Tips To Maintain Your Pharmaceutical Tablet Presses And ToolingImplementing a cleaning procedure is essential to maintaining tablet tooling and presses. Clean tooling reduces product cross-contamination risk and decreases premature wear.
-
Impact Of Water Activity On The Potency, Purity And Bioavailability Of Oral Solid Dosage Products11/21/2022
Explore laser-based headspace analysis, the impact of USP<922> Water Activity on primary packing selection, and the impact of water activity on the potency, purity, and bioavailability of OSD products.
-
Tablet Characterization With Regulatory Compliance Method USP<1062>9/26/2022
This video explores different punch cup configuration, the comparison compression and granulation techniques, and how it impacts USP<1062> profiles.
-
An Easy-To-Swallow Depression Drug For Elderly Patients4/20/2023
Examine how an innovative formulation approach helped a developer create a version of their drug that promotes treatment compliance within the geriatric population.
-
Challenges Associated With Building New Isolator Technology3/26/2024
Paula Rizo, Germfree’s Mechanical Engineering Lead for Equipment, dives deeper into our collaboration with AST and how this isolator technology will transform the way pharmaceutical companies approach aseptic processing.
-
How Tablet Shapes Impact Patient Acceptance7/6/2022
Explore how a tablet's size, shape, and color can improve product appeal and influence consumer preference.
SOLID DOSE MANUFACTURING SOLUTIONS
-
![Pharma downflow Booths]( "Pharmaceutical Downflow Booths")
When you need to provide a clean, contained environment for the safe handling of powders in dispensing, weighing, sampling, or subdivision operations, our PharmAir booths are a highly effective option. Complete containment solutions based around an innovative range of Downflow Containment Booths that bring different features and benefits to your application. But all have one thing in common: they give a Guaranteed Working Environment.
-
![Used Sejong Pharmaceutical Encapsulator]( "Used Sejong Pharmaceutical Encapsulator")
Used Sejong Encapsulator, with change parts/tooling, 600 volts, 3 phase.
-
![Dec Group Sterile Process small]( "Overcoming Aseptic Manufacturing Challenges To Prevent Contamination")
The pharmaceutical industry has steadily moved to increased production and handling of sterile highly potent active ingredients (HPAPIs). Dec’s containment technologies comply with pharmaceutical quality manufacturing standards and are available for aseptic operations.
-
![Lyophilizer Cryodesiccation Suite]( "Pharmaceutical Freeze Dryer Cryodesiccation Suite")
The Lyophilizer Cryodesiccation Suite designed to provide personnel protection while working with powder substances. Designed to work with a lyophilizer with dimensions 450mm (L) x 450mm (W) x 450 mm (H) (17.72” L x 17.72” W x 17.72” H).
-
![LAXAI-Drug Substance]( "Drug Substance Services")
Examine our drug product manufacturing capabilities and how our skilled scientists work with customers to build a chemical in a cost-effective and timely manner throughout the clinical development process.
